Advertisement
Screener

PAR PHARMACEUTICAL COMPANIES, INC. Forms 3, 4 and 5: Stock Options, 2006

PAR PHARMACEUTICAL COMPANIES, INC. Forms 3, 4 and 5: Stock Options

Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 22 rows in 2006. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.

  • 2006-11-01: Reporting owner LEPORE PATRICK G; Form 4; Security Common Stock, Option to Buy; Transaction Holding.
  • 2006-10-30: Reporting owner LEPORE PATRICK G; Form 4; Security Common Stock, Option to Buy; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
  • 2006-06-20: Reporting owner LEPORE PATRICK G; Form 3/A; Security Common Stock, Option to Buy; Transaction Holding.
  • 2006-05-30: Reporting owner LEPORE PATRICK G; Form 3; Security Common Stock, Option to Buy; Transaction Holding.
Transaction dateReporting ownerFormSecurityTransactionSharesPricePrice that dayFiling
2006-11-01
holding as of filing
LEPORE PATRICK G
Director, Officer (Chief Executive Officer & Pres)
4Common Stock, Option to Buy
Derivative · Direct
Holding
5,000 owned after
$22.20
exercise price
2006-11-01
2006-10-30LEPORE PATRICK G
Director, Officer (Chief Executive Officer & Pres)
4Common Stock, Option to Buy
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+120,000
120,000 owned after
$19.26
exercise price
2006-11-01
2006-06-20
holding as of filing
LEPORE PATRICK G
Director
3/ACommon Stock, Option to Buy
Derivative · Direct
Holding$22.20
exercise price
2006-06-20
2006-05-30
holding as of filing
LEPORE PATRICK G
Director
3Common Stock, Option to Buy
Derivative · Direct
Holdingno price filed2006-05-30
2006-03-17
holding as of filing
Martino Gerard
Officer (Vice President & CFO)
3Option to Buy
Derivative · Direct
Holding$27.24
exercise price
2006-03-17
2006-01-26GUTMAN ARIE
Other (Former Director & Officer)
4Common Stock, Option to Buy
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−6,700
0 owned after
$21.65
exercise price
2006-01-30
2006-01-25GUTMAN ARIE
Other (Former Director & Officer)
4Common Stock, Option to Buy
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3+60,000
6,700 owned after
$21.65
exercise price
2006-01-25
2006-01-24GUTMAN ARIE
Other (Former Director & Officer)
4Common Stock, Option to Buy
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−23,300
66,700 owned after
$21.65
exercise price
2006-01-25
2006-01-23GUTMAN ARIE
Other (Former Director & Officer)
4Common Stock, Option to Buy
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−60,000
90,000 owned after
$21.65
exercise price
2006-01-25
2006-01-09KNIGHT PETER S
Director
4Common Stock, Option to Buy
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+5,000
5,000 owned after
$33.62
exercise price
2006-01-11
2006-01-09SMITH JOSEPH E
Director
4Common Stock, Option to Buy
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+5,000
5,000 owned after
$33.62
exercise price
2006-01-11
2006-01-09MacPhee John A
Officer (Pres, Branded Products Div)
4Common Stock, Option to Buy
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+18,319
18,319 owned after
$33.62
exercise price
2006-01-11
2006-01-09Graves Michael
Officer (Pres, Generic Products Div)
4Common Stock, Option to Buy
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+9,892
9,892 owned after
$33.62
exercise price
2006-01-11
2006-01-09Hariharan Shankar
Officer (VP, Chief Scientific Officer)
4Common Stock, Option to Buy
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+14,992
14,992 owned after
$33.62
exercise price
2006-01-11
2006-01-09HAUGHEY THOMAS
Officer (VP, General Counsel, Secy)
4Common Stock, Option to Buy
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+14,992
14,992 owned after
$33.62
exercise price
2006-01-11
2006-01-09AUERBACH MARK
Director, Officer (Executive Chairman)
4Common Stock, Option to Buy
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+59,971
59,971 owned after
$33.62
exercise price
2006-01-11
2006-01-09O CONNOR DENNIS J
Officer (Vice President, CFO)
4Common Stock, Option to Buy
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+7,005
7,005 owned after
$33.62
exercise price
2006-01-11
2006-01-09TARRIFF SCOTT L
Director, Officer (President & CEO)
4Common Stock, Option to Buy
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+119,942
119,942 owned after
$33.62
exercise price
2006-01-11
2006-01-09SEIDMAN L WILLIAM
Director
4Common Stock, Option to Buy
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+5,000
5,000 owned after
$33.62
exercise price
2006-01-11
2006-01-09WILLIAMS PETER
Director
4Common Stock, Option to Buy
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+5,000
5,000 owned after
$33.62
exercise price
2006-01-11
2006-01-09NORDMANN RONALD M
Director
4Common Stock, Option to Buy
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+5,000
5,000 owned after
$33.62
exercise price
2006-01-11
2006-01-09ABERNATHY JOHN D
Director
4Common Stock, Option to Buy
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+5,000
5,000 owned after
$33.62
exercise price
2006-01-11